OXYTOCIN Side Effects

6937348-2 | Postpartum Haemorrhage
on Aug 13, 2010 Female patient from UNITED STATES , 20 years of age, weighting 123.5 lb, was diagnosed with labour induction, pain management and was treated with Oxytocin (View Usage). Patient experienced the following unwanted or unexpected effects: postpartum haemorrhage. Oxytocin dosage: . During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), BUPIVACAINE HCL (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ).

6937347-0 | Postpartum Haemorrhage
Patient was taking Oxytocin (View Usage). Patient had the following side effects: postpartum haemorrhage on Aug 13, 2010 from UNITED STATES Additional patient health information: Female patient , 21 years of age, weighting 202.8 lb, was diagnosed with labour induction, pain management and. Oxytocin dosage: . During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), BUPIVACAINE HCL (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), STADOL (View Stadol Review and Stadol Label ), ANCEF (View Ancef Review and Ancef Label ).

6937346-9 | Postpartum Haemorrhage
Adverse event was reported on Aug 13, 2010 by a Female patient taking Oxytocin (View Usage) (Dosage: ) was diagnosed with labour induction, pain management and. Location: UNITED STATES , 31 years of age, weighting 282.2 lb, After Oxytocin was administered, patient had the following side effects: postpartum haemorrhage. During the same period patient was treated with MORPHINE EPIDURAL ^PHARMACIA + UPJOHN^ (View Morphine Epidural ^pharmacia + Upjohn^ Review and Morphine Epidural ^pharmacia + Upjohn^ Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), BUPIVACAINE HCL (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), PENICILLIN G (View Penicillin G Review and Penicillin G Label ).

6937327-5 | Postpartum Haemorrhage
on Aug 13, 2010 Female patient from UNITED STATES , 17 years of age, weighting 163.1 lb, was diagnosed with labour induction, pain management and was treated with Oxytocin (View Usage). Patient experienced the following unwanted or unexpected effects: postpartum haemorrhage. Oxytocin dosage: . During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), BUPIVACAINE HCL (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), STADOL (View Stadol Review and Stadol Label ), LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER (View Lactated Ringer's And Dextrose 5% In Plastic Container Review and Lactated Ringer's And Dextrose 5% In Plastic Container Label ).


6708982-X | Arteriosclerosis Coronary Artery, Cardiac Failure Acute, Cardiogenic Shock, Coronary Arterial Stent Insertion, Coronary Artery Disease, Coronary Artery Stenosis, Electrocardiogram St Segment Depression, Extracorporeal Membrane Oxygenation, Left Ventricular Dysfunction
on Apr 29, 2010 Female patient from GERMANY , 36 years of age, was treated with Oxytocin (View Usage). Patient had the following side effects: arteriosclerosis coronary artery, cardiac failure acute, cardiogenic shock, coronary arterial stent insertion, coronary artery disease (What is coronary artery disease?), coronary artery stenosis, electrocardiogram st segment depression, extracorporeal membrane oxygenation, left ventricular dysfunction. Oxytocin dosage: . During the same period patient was treated with METHERGINE (View Methergine Review and Methergine Label ).

6696091-8 | Cardiac Arrest, Circulatory Collapse, Haematocrit Decreased, Heart Rate Increased, Hyperhidrosis, Hypotension, Hysterectomy, Laparotomy
Patient was taking Oxytocin (View Usage). After Oxytocin was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), circulatory collapse, haematocrit decreased, heart rate increased, hyperhidrosis, hypotension, hysterectomy (What is hysterectomy?), laparotomy on Apr 21, 2010 from TURKEY Additional patient health information: Female patient , 35 years of age, was diagnosed with haemorrhage and. Oxytocin dosage: 1 Mu/min.

6666908-1 | Haematemesis, Pulmonary Oedema, Renal Failure Acute
Adverse event was reported on Mar 22, 2010 by a Female patient taking Oxytocin (View Usage) (Dosage: ) was diagnosed with postpartum haemorrhage, shock and. Location: INDIA , 35 years of age, weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: haematemesis, pulmonary oedema, renal failure acute. During the same period patient was treated with METHERGINE (View Methergine Review and Methergine Label ), PROSTAGLANDIN F2 ALPHA (View Prostaglandin F2 Alpha Review and Prostaglandin F2 Alpha Label ), GELATIN (500 Ml, Unk) (View Gelatin Review and Gelatin Label ), PLATELETS (2 Units) (View Platelets Review and Platelets Label ), BLOOD, WHOLE (View Blood, Whole Review and Blood, Whole Label ).

6623893-6 | Apnoea, Discomfort, Dyspnoea, Heart Rate Decreased, Loss Of Consciousness, Oxygen Saturation Decreased, Unresponsive To Stimuli
on Mar 04, 2010 Female patient from NEPAL , 24 years of age, was treated with Oxytocin (View Usage). Patient had the following side effects: apnoea, discomfort, dyspnoea, heart rate decreased, loss of consciousness, oxygen saturation decreased, unresponsive to stimuli. Oxytocin dosage: 15 U In Remaining 350 Ml Rl. Patient was hospitalized.

6592741-5 | Procedural Hypotension
on Jan 25, 2010 Female patient from CANADA , 34 years of age, was diagnosed with haemostasis and was treated with Oxytocin (View Usage). After Oxytocin was administered, patient had the following side effects: procedural hypotension. Oxytocin dosage: (300 Ml), Intravenous. During the same period patient was treated with MARCAINE (View Marcaine Review and Marcaine Label ), EPIMORPH (View Epimorph Review and Epimorph Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), ANCEF (View Ancef Review and Ancef Label ).

6592740-3 | Procedural Hypotension
Patient was taking Oxytocin (View Usage). Patient experienced the following unwanted or unexpected effects: procedural hypotension on Jan 25, 2010 from CANADA Additional patient health information: Female patient , 23 years of age, was diagnosed with caesarean section, uterine haemorrhage and. Oxytocin dosage: (200 Ml), Intravenous. During the same period patient was treated with MARCAINE (View Marcaine Review and Marcaine Label ), EPIMORPH (View Epimorph Review and Epimorph Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ANCEF (View Ancef Review and Ancef Label ).

6518987-X | Apnoea, Bradycardia, Hyponatraemia, Overdose, Urine Output Decreased
Adverse event was reported on Dec 17, 2009 by a Female patient taking Oxytocin (View Usage) (Dosage: ) was diagnosed with accidental exposure and. Location: UNITED STATES , weighting 4.41 lb, Patient had the following side effects: apnoea, bradycardia, hyponatraemia, overdose, urine output decreased. During the same period patient was treated with NORMAL SALINE (View Normal Saline Review and Normal Saline Label ), HEPARIN (View Heparin Review and Heparin Label ), DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (View Dextrose 10% And Sodium Chloride 0.9% In Plastic Container Review and Dextrose 10% And Sodium Chloride 0.9% In Plastic Container Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ).

6492580-X | Normal Newborn, Retained Placenta Or Membranes, Uterine Atony, Vaginal Haemorrhage
on Nov 30, 2009 Female patient from AUSTRALIA , 28 years of age, was treated with Oxytocin (View Usage). After Oxytocin was administered, patient had the following side effects: normal newborn, retained placenta or membranes, uterine atony, vaginal haemorrhage. Oxytocin dosage: 10 Iu, Unk.

6244924-1 | Activated Partial Thromboplastin Time Prolonged, Agitation, Anaphylactic Shock, Blood Pressure Immeasurable, Disseminated Intravascular Coagulation, Dyspnoea, Haematocrit Decreased, Haemoglobin Decreased, Hyperhidrosis
on Jun 15, 2009 Female patient from BRAZIL , 35 years of age, was treated with Oxytocin (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, agitation, anaphylactic shock, blood pressure immeasurable, disseminated intravascular coagulation, dyspnoea, haematocrit decreased, haemoglobin decreased, hyperhidrosis. Oxytocin dosage: 5 U, Unk. During the same period patient was treated with RINGER'S (View Ringer's Review and Ringer's Label ), CEPHALOTHIN (1 G, Unk) (View Cephalothin Review and Cephalothin Label ), ERGOTRATE (View Ergotrate Review and Ergotrate Label ), SODIUM CHLORIDE (500 Ml, Unk) (View Sodium Chloride Review and Sodium Chloride Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), FENTANYL (20 Ug, Unk) (View Fentanyl Review and Fentanyl Label ), OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

6141231-2 | Arrested Labour, Caesarean Section, Catheter Related Complication, Endotracheal Intubation, Epidural Anaesthesia, Heart Valve Stenosis, Increased Bronchial Secretion, Mechanical Ventilation
Patient was taking Oxytocin (View Usage). Patient had the following side effects: arrested labour, caesarean section, catheter related complication, endotracheal intubation, epidural anaesthesia, heart valve stenosis, increased bronchial secretion, mechanical ventilation on Mar 31, 2009 from INDIA Additional patient health information: Female patient , 22 years of age, was diagnosed with induced labour and. Oxytocin dosage: 6 Milli Iu/min Gradually Increased To 40 Milli Iu/min. During the same period patient was treated with FENTANYL 25 (25 Ug) (View Fentanyl-25 Review and Fentanyl-25 Label ), FENTANYL 25 (0.0002% @ 5 Ml/hour) (View Fentanyl-25 Review and Fentanyl-25 Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), SUCCINYLCHOLINE (View Succinylcholine Review and Succinylcholine Label ), OXYGEN (View Oxygen Review and Oxygen Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ). Patient was hospitalized.

6083591-7 | Disseminated Intravascular Coagulation, Haemorrhage, Hysterectomy, Laparotomy, Mechanical Ventilation, Postpartum Haemorrhage, Splenectomy, Splenic Artery Aneurysm, Uterine Atony
Adverse event was reported on Feb 17, 2009 by a Female patient taking Oxytocin (View Usage) (Dosage: ) . Location: INDIA , 32 years of age, After Oxytocin was administered, patient had the following side effects: disseminated intravascular coagulation, haemorrhage, hysterectomy (What is hysterectomy?), laparotomy, mechanical ventilation, postpartum haemorrhage, splenectomy, splenic artery aneurysm, uterine atony. During the same period patient was treated with ERGOMETRINE (View Ergometrine Review and Ergometrine Label ), CARBOPROST (View Carboprost Review and Carboprost Label ). Patient was hospitalized.

6082696-4 | Acute Respiratory Failure, Blood Lactate Dehydrogenase Increased, Cardiac Disorder, Cardiac Failure, Crepitations, Dyspnoea, Ejection Fraction Decreased, Endotracheal Intubation, Heart Rate Increased
on Feb 12, 2009 Female patient from NETHERLANDS , 28 years of age, was diagnosed with delivery, uterine atony and was treated with Oxytocin (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, blood lactate dehydrogenase increased, cardiac disorder, cardiac failure, crepitations, dyspnoea, ejection fraction decreased, endotracheal intubation, heart rate increased. Oxytocin dosage: . During the same period patient was treated with DIURETICS (View Diuretics Review and Diuretics Label ), ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ), SULPROSTONE (View Sulprostone Review and Sulprostone Label ). Patient was hospitalized.

6054539-6 | Arrested Labour, Caesarean Section, Haemorrhage, Premature Labour, Umbilical Cord Abnormality
on Jan 21, 2009 Female patient from NETHERLANDS , 32 years of age, was diagnosed with uterine contractions abnormal and was treated with Oxytocin (View Usage). Patient had the following side effects: arrested labour, caesarean section, haemorrhage, premature labour, umbilical cord abnormality. Oxytocin dosage: . During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ). Patient was hospitalized.

6054519-0 | Artificial Rupture Of Membranes, Epidural Anaesthesia, Haematocrit Decreased, Haemoglobin Decreased, Postpartum Haemorrhage, Uterine Atony
Patient was taking Oxytocin (View Usage). After Oxytocin was administered, patient had the following side effects: artificial rupture of membranes, epidural anaesthesia, haematocrit decreased, haemoglobin decreased, postpartum haemorrhage, uterine atony on Jan 19, 2009 from UNITED STATES Additional patient health information: Female patient , 25 years of age, was diagnosed with labour induction and. Oxytocin dosage: 1 Mu Every 15 Minutes Or A Maximum Dose Of 20 Mu/min. During the same period patient was treated with METHERGINE (View Methergine Review and Methergine Label ). Patient was hospitalized.

6054516-5 | Arrested Labour, Caesarean Section, Catheter Related Complication, Endotracheal Intubation, Epidural Anaesthesia, Heart Valve Stenosis, Increased Bronchial Secretion, Mechanical Ventilation
Adverse event was reported on Jan 19, 2009 by a Female patient taking Oxytocin (View Usage) (Dosage: 6 Milli Iu/min Gradually Increased To 40 Milli Iu/min) was diagnosed with induced labour and. Location: INDIA , 22 years of age, Patient experienced the following unwanted or unexpected effects: arrested labour, caesarean section, catheter related complication, endotracheal intubation, epidural anaesthesia, heart valve stenosis, increased bronchial secretion, mechanical ventilation. During the same period patient was treated with FENTANYL CITRATE (25 Ug) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), SUCCINYLCHOLINE CHLORIDE (View Succinylcholine Chloride Review and Succinylcholine Chloride Label ), OXYGEN (View Oxygen Review and Oxygen Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ). Patient was hospitalized.

6050512-2 | Arrested Labour, Artificial Rupture Of Membranes, Caesarean Section, Normal Newborn, Premature Separation Of Placenta
on Jan 21, 2009 Female patient from NETHERLANDS , 28 years of age, was diagnosed with induced labour and was treated with Oxytocin (View Usage). Patient had the following side effects: arrested labour, artificial rupture of membranes, caesarean section, normal newborn, premature separation of placenta. Oxytocin dosage: . Patient was hospitalized.

5970958-8 | Hysterectomy, Laparotomy, Postpartum Haemorrhage, Sciatic Nerve Neuropathy, Therapeutic Embolisation, Uterine Atony
on Nov 19, 2008 Female patient from NETHERLANDS , 33 years of age, was diagnosed with artificial rupture of membranes and was treated with Oxytocin (View Usage). After Oxytocin was administered, patient had the following side effects: hysterectomy (What is hysterectomy?), laparotomy, postpartum haemorrhage, sciatic nerve neuropathy, therapeutic embolisation, uterine atony. Oxytocin dosage: .

5964967-2 | Arterial Ligation, Hysterotomy, Obstetrical Procedure, Suture Insertion, Uterine Atony
Patient was taking Oxytocin (View Usage). Patient experienced the following unwanted or unexpected effects: arterial ligation, hysterotomy, obstetrical procedure, suture insertion, uterine atony on Nov 13, 2008 from FRANCE Additional patient health information: Female patient , 29 years of age, was diagnosed with postpartum haemorrhage and. Oxytocin dosage: . During the same period patient was treated with SULPROSTONE (View Sulprostone Review and Sulprostone Label ).

5908613-2 | Caesarean Section, Uterine Contractions Abnormal
Adverse event was reported on Sep 24, 2008 by a Female patient taking Oxytocin (View Usage) (Dosage: 30 Units/500 Ml (rate Of 5 Mu/minute), Intravenous Drip) was diagnosed with labour induction and. Location: UNITED STATES , 24 years of age, weighting 165.3 lb, Patient had the following side effects: caesarean section, uterine contractions abnormal.

5893358-8 | Blood Pressure Increased, Chills
on Sep 22, 2008 Female patient from UNITED STATES , 20 years of age, weighting 182.1 lb, was diagnosed with caesarean section and was treated with Oxytocin (View Usage). After Oxytocin was administered, patient had the following side effects: blood pressure increased, chills. Oxytocin dosage: 125 Ml/hr Once Iv Drip.

5892705-0 | Echocardiogram Abnormal, Electrocardiogram St Segment Depression, Troponin Increased
on Sep 17, 2008 Female patient from BERMUDA , 19 years of age, was treated with Oxytocin (View Usage). Patient experienced the following unwanted or unexpected effects: echocardiogram abnormal, electrocardiogram st segment depression, troponin increased. Oxytocin dosage: .

5889892-7 | Acute Myocardial Infarction, Cardiopulmonary Bypass, Cardioversion, Cyanosis, Feeling Hot, Heart Valve Replacement, Hepatic Haematoma, Hypotension, Left Ventricular Hypertrophy
Patient was taking Oxytocin (View Usage). Patient had the following side effects: acute myocardial infarction, cardiopulmonary bypass, cardioversion, cyanosis, feeling hot, heart valve replacement, hepatic haematoma, hypotension, left ventricular hypertrophy on Sep 10, 2008 from UNITED STATES Additional patient health information: Female patient , 29 years of age, was diagnosed with abortion induced and. Oxytocin dosage: 0.5 Cc. During the same period patient was treated with MEPIVACAINE HCL (View Mepivacaine Hcl Review and Mepivacaine Hcl Label ), PENTOBARBITAL CAP (100 Mg) (View Pentobarbital Cap Review and Pentobarbital Cap Label ).

5874561-X | Abdominal Compartment Syndrome, Abdominal Distension, Activated Partial Thromboplastin Time Prolonged, Blood Fibrinogen Decreased, Blood Ph Increased, Bradycardia Foetal, Breakthrough Pain, Catheter Placement, Depressed Level Of Consciousness
Adverse event was reported on Sep 03, 2008 by a Female patient taking Oxytocin (View Usage) (Dosage: ) was diagnosed with induced labour and. Location: UNITED STATES , 43 years of age, After Oxytocin was administered, patient had the following side effects: abdominal compartment syndrome, abdominal distension, activated partial thromboplastin time prolonged, blood fibrinogen decreased, blood ph increased, bradycardia foetal, breakthrough pain, catheter placement, depressed level of consciousness. During the same period patient was treated with BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), FENTANYL (2 Ug/ml, Unk) (View Fentanyl Review and Fentanyl Label ), EPHEDRINE SUL CAP (View Ephedrine Sul Cap Review and Ephedrine Sul Cap Label ), METHYLERGOMETRINE (View Methylergometrine Review and Methylergometrine Label ), MISOPROSTOL (View Misoprostol Review and Misoprostol Label ), HEPARIN (View Heparin Review and Heparin Label ).

5872440-5 | Acidosis, Chest Pain, Dilatation Ventricular, Dyspnoea, Ejection Fraction Decreased, Endotracheal Intubation, Hyperkinesia, Hypotension, Hypoxia
on Aug 28, 2008 Female patient from ITALY , 42 years of age, weighting 189.6 lb, was diagnosed with uterine haemorrhage and was treated with Oxytocin (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, chest pain (What is chest pain?), dilatation ventricular, dyspnoea, ejection fraction decreased, endotracheal intubation, hyperkinesia, hypotension, hypoxia. Oxytocin dosage: . During the same period patient was treated with ERGONOVINE (View Ergonovine Review and Ergonovine Label ), BUPIVACAINE (10 Mg, Unk) (View Bupivacaine Review and Bupivacaine Label ), FENTANYL 25 (20 Ug, Unk) (View Fentanyl-25 Review and Fentanyl-25 Label ), MORPHINE (0.25 Mg, Unk) (View Morphine Review and Morphine Label ). Patient was hospitalized.

5867380-1 | Cardiac Output Increased, Mean Arterial Pressure Decreased, Vascular Resistance Systemic Decreased
on Aug 22, 2008 Female patient from UNITED STATES , 27 years of age, weighting 137.3 lb, was treated with Oxytocin (View Usage). Patient had the following side effects: cardiac output increased, mean arterial pressure decreased, vascular resistance systemic decreased. Oxytocin dosage: . During the same period patient was treated with NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), METHYLDOPA (500 Mg, Tid) (View Methyldopa Review and Methyldopa Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ), MAGNESIUM SULFATE (2 G/h) (View Magnesium Sulfate Review and Magnesium Sulfate Label ), SODIUM CITRATE (30 Ml, Unk) (View Sodium Citrate Review and Sodium Citrate Label ), METOCLOPRAMIDE (10 Mg, Unk) (View Metoclopramide Review and Metoclopramide Label ), FAMOTIDINE (20 Mg, Unk) (View Famotidine Review and Famotidine Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ).

5867363-1 | Cardiac Output Increased, Mean Arterial Pressure Decreased, Stroke Volume Increased, Vascular Resistance Systemic Decreased
Patient was taking Oxytocin (View Usage). After Oxytocin was administered, patient had the following side effects: cardiac output increased, mean arterial pressure decreased, stroke volume increased, vascular resistance systemic decreased on Aug 22, 2008 from UNITED STATES Additional patient health information: Female patient , 29 years of age, . Oxytocin dosage: . During the same period patient was treated with LABETALOL HCL (100 Mg, Bid) (View Labetalol Hcl Review and Labetalol Hcl Label ), MAGNESIUM SULFATE (4 G, Unk) (View Magnesium Sulfate Review and Magnesium Sulfate Label ), SODIUM CITRATE (30 Ml, Unk) (View Sodium Citrate Review and Sodium Citrate Label ), CLINDAMYCIN HCL (900 Mg, Unk) (View Clindamycin Hcl Review and Clindamycin Hcl Label ), FAMOTIDINE (20 Mg, Unk) (View Famotidine Review and Famotidine Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), FENTANYL 25 (25 Ug, Unk) (View Fentanyl-25 Review and Fentanyl-25 Label ), MORPHINE (200 Ug, Unk) (View Morphine Review and Morphine Label ).

5867347-3 | Cardiac Output Increased, Mean Arterial Pressure Decreased, Vascular Resistance Systemic Decreased
Adverse event was reported on Aug 22, 2008 by a Female patient taking Oxytocin (View Usage) (Dosage: 10 U, Unk) . Location: UNITED STATES , 24 years of age, Patient experienced the following unwanted or unexpected effects: cardiac output increased, mean arterial pressure decreased, vascular resistance systemic decreased. During the same period patient was treated with SODIUM CITRATE (30 Ml, Unk) (View Sodium Citrate Review and Sodium Citrate Label ), METOCLOPRAMIDE (10 Mg, Unk) (View Metoclopramide Review and Metoclopramide Label ), FAMOTIDINE (20 Mg, Unk) (View Famotidine Review and Famotidine Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), BUPIVACAINE (2.4 Mg, Unk) (View Bupivacaine Review and Bupivacaine Label ), FENTANYL 25 (5 Ug, Unk) (View Fentanyl-25 Review and Fentanyl-25 Label ), MORPHINE (40 Ug, Unk) (View Morphine Review and Morphine Label ), PHENYLEPHRINE (100 Ug, Unk) (View Phenylephrine Review and Phenylephrine Label ).

5867346-1 | Hypotension, Nausea
on Aug 22, 2008 Female patient from UNITED STATES , 35 years of age, weighting 427.7 lb, was treated with Oxytocin (View Usage). Patient had the following side effects: hypotension, nausea (What is nausea?). Oxytocin dosage: . During the same period patient was treated with MAGNESIUM SULFATE (2 G/h) (View Magnesium Sulfate Review and Magnesium Sulfate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), METOCLOPRAMIDE (10 Mg, Unk) (View Metoclopramide Review and Metoclopramide Label ), FAMOTIDINE (20 Mg, Unk) (View Famotidine Review and Famotidine Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), FENTANYL 25 (View Fentanyl-25 Review and Fentanyl-25 Label ), MORPHINE (View Morphine Review and Morphine Label ).

5863972-4 | Cardiac Output Increased, Mean Arterial Pressure Decreased, Stroke Volume Increased, Vascular Resistance Systemic Decreased
on Aug 22, 2008 Female patient from UNITED STATES , 26 years of age, was treated with Oxytocin (View Usage). After Oxytocin was administered, patient had the following side effects: cardiac output increased, mean arterial pressure decreased, stroke volume increased, vascular resistance systemic decreased. Oxytocin dosage: 5 U, Unk. During the same period patient was treated with PHENYLEPHRINE (50 Ug, Unk) (View Phenylephrine Review and Phenylephrine Label ), SODIUM CHLORIDE (250 Ml, Unk) (View Sodium Chloride Review and Sodium Chloride Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), FENTANYL 25 (100 Ug, Unk) (View Fentanyl-25 Review and Fentanyl-25 Label ).

5843202-X | Haemoglobin Decreased, Pyrexia, Retained Placenta Or Membranes, Uterine Mass, Vaginal Haemorrhage
Patient was taking Oxytocin (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, pyrexia, retained placenta or membranes, uterine mass, vaginal haemorrhage on Aug 05, 2008 from SINGAPORE Additional patient health information: Female patient , 33 years of age, . Oxytocin dosage: . During the same period patient was treated with DURATOCIN (View Duratocin Review and Duratocin Label ), ERGOMETRINE (View Ergometrine Review and Ergometrine Label ), PLASMA (View Plasma Review and Plasma Label ). Patient was hospitalized.

5815911-X | Uterine Hypertonus
Adverse event was reported on Jul 16, 2008 by a Female patient taking Oxytocin (View Usage) (Dosage: ) was diagnosed with labour stimulation and. Location: UNITED STATES , 33 years of age, weighting 285.0 lb, Patient had the following side effects: uterine hypertonus.

5809381-5 | Abortion Induced, Alpha 1 Foetoprotein Decreased, Computerised Tomogram Abnormal, Dermoid Cyst, Dyspnoea, Ovarian Cyst
on Jul 10, 2008 Female patient from THAILAND , 27 years of age, was treated with Oxytocin (View Usage). After Oxytocin was administered, patient had the following side effects: abortion induced, alpha 1 foetoprotein decreased, computerised tomogram abnormal, dermoid cyst, dyspnoea, ovarian cyst (What is ovarian cyst?). Oxytocin dosage: . Patient was hospitalized.

5786001-X | Acute Pulmonary Oedema, Blood Immunoglobulin E Increased, Brain Oedema, Bronchospasm, Cardiac Arrest, Chemical Poisoning, Endotracheal Intubation, Haemoglobin Decreased, Hypotension
on Jun 23, 2008 Female patient from ITALY , 33 years of age, was diagnosed with caesarean section and was treated with Oxytocin (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, blood immunoglobulin e increased, brain oedema, bronchospasm, cardiac arrest (What is cardiac arrest?), chemical poisoning, endotracheal intubation, haemoglobin decreased, hypotension. Oxytocin dosage: Unk,unk. During the same period patient was treated with BUPIVACAINE (2.2 Ml, Once/single) (View Bupivacaine Review and Bupivacaine Label ). Patient was hospitalized.

5772457-5 | Apgar Score Low, Foetal Distress Syndrome
Patient was taking Oxytocin (View Usage). Patient had the following side effects: apgar score low, foetal distress syndrome on May 21, 2008 from FRANCE Additional patient health information: Female patient , weighting 5.42 lb, was diagnosed with induced labour, threatened labour and. Oxytocin dosage: Unk. During the same period patient was treated with DINOPROSTONE (10 Mg) (View Dinoprostone Review and Dinoprostone Label ), ANAESTHETICS (Unk) (View Anaesthetics Review and Anaesthetics Label ), NIFEDIPINE (Unk,unk) (View Nifedipine Review and Nifedipine Label ), PHLOROGLUCINOL (View Phloroglucinol Review and Phloroglucinol Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ).

5762839-X | Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb Increased, Blood Pressure Decreased, Chest Pain, Myocardial Infarction, Troponin T Increased
Adverse event was reported on Apr 11, 2008 by a Female patient taking Oxytocin (View Usage) (Dosage: 3 U, Unk) was diagnosed with spinal anaesthesia and. Location: GERMANY , 22 years of age, After Oxytocin was administered, patient had the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood pressure decreased, chest pain (What is chest pain?), myocardial infarction, troponin t increased. During the same period patient was treated with METOPROLOL TARTRATE (9 Mg, Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), MIDAZOLAM HCL (4.5 Mg, Unk) (View Midazolam Hcl Review and Midazolam Hcl Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ). Patient was hospitalized.

5723998-8 | Cardiac Arrest, Circulatory Collapse, Haematocrit Decreased, Heart Rate Increased, Hyperhidrosis, Hypotension, Hysterectomy, Laparotomy
on Apr 29, 2008 Female patient from TURKEY , 35 years of age, was diagnosed with haemorrhage and was treated with Oxytocin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), circulatory collapse, haematocrit decreased, heart rate increased, hyperhidrosis, hypotension, hysterectomy (What is hysterectomy?), laparotomy. Oxytocin dosage: 1 Mu/min.

5614990-2 | Abnormal Labour, Bradycardia Foetal, Caesarean Section, Hysterectomy, Uterine Atony, Uterine Disorder, Uterine Haemorrhage, Uterine Hypertonus, Uterine Hypotonus
on Jan 28, 2008 Female patient from UNITED STATES , 39 years of age, was diagnosed with labour induction and was treated with Oxytocin (View Usage). Patient had the following side effects: abnormal labour, bradycardia foetal, caesarean section, hysterectomy (What is hysterectomy?), uterine atony, uterine disorder, uterine haemorrhage, uterine hypertonus, uterine hypotonus. Oxytocin dosage: 6 Mu/min. During the same period patient was treated with MISOPROSTOL (View Misoprostol Review and Misoprostol Label ), ANESTHETICS, LOCAL (View Anesthetics, Local Review and Anesthetics, Local Label ). Patient was hospitalized.

5481221-6 | Mean Arterial Pressure Decreased, Right Atrial Pressure Increased
Patient was taking Oxytocin (View Usage). After Oxytocin was administered, patient had the following side effects: mean arterial pressure decreased, right atrial pressure increased on Oct 02, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 32 years of age, . Oxytocin dosage: 5 Iu, Unk. During the same period patient was treated with BOSENTAN (125 Mg, Bid) (View Bosentan Review and Bosentan Label ), SILDENAFIL (25 Mg, Tid) (View Sildenafil Review and Sildenafil Label ), PROSTACYCLIN (5 Ng/kg/min) (View Prostacyclin Review and Prostacyclin Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ), DIAMORPHINE (400 Ug, Unk) (View Diamorphine Review and Diamorphine Label ), LEVOBUPIVACAINE (View Levobupivacaine Review and Levobupivacaine Label ). Patient was hospitalized.

5481208-3 | Acute Right Ventricular Failure, Hypotension, Pulmonary Arterial Pressure Increased, Right Atrial Pressure Increased
Adverse event was reported on Oct 02, 2007 by a Female patient taking Oxytocin (View Usage) (Dosage: 0.25 Iu Followed By Further 0.25 Iu) . Location: UNITED KINGDOM , 33 years of age, Patient experienced the following unwanted or unexpected effects: acute right ventricular failure, hypotension, pulmonary arterial pressure increased, right atrial pressure increased. During the same period patient was treated with PROSTACYCLIN (4 Ng/kg/min) (View Prostacyclin Review and Prostacyclin Label ), HEPARIN (View Heparin Review and Heparin Label ), MIDAZOLAM HCL (1 Mg, Unk) (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (350 Ug, Unk) (View Fentanyl Review and Fentanyl Label ), THIOPENTONE (175 Mg, Unk) (View Thiopentone Review and Thiopentone Label ), SUXAMETHONIUM (100 Mg, Unk) (View Suxamethonium Review and Suxamethonium Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ). Patient was hospitalized.

5389828-1 | Dizziness, Loss Of Consciousness, Muscle Twitching, Somnolence, Visual Disturbance
on Jul 11, 2007 Female patient from AUSTRALIA , 35 years of age, weighting 187.4 lb, was treated with Oxytocin (View Usage). Patient had the following side effects: dizziness (What is dizziness?), loss of consciousness, muscle twitching, somnolence, visual disturbance. Oxytocin dosage: 30 Mg, 1 Time. During the same period patient was treated with MARCAINE (2 Ml, 1 Time) (View Marcaine Review and Marcaine Label ), CEFAZOLIN SODIUM (1 G, 1 Time) (View Cefazolin Sodium Review and Cefazolin Sodium Label ), FLAGYL (500 Mg, 1 Time) (View Flagyl Review and Flagyl Label ), INDOMETHACIN (100 Mg, 1 Time) (View Indomethacin Review and Indomethacin Label ), PHENERGAN HCL (1 Time) (View Phenergan Hcl Review and Phenergan Hcl Label ), FENTANYL (500 Ug, Daily) (View Fentanyl Review and Fentanyl Label ).

5346079-4 | Asphyxia, Bradycardia Foetal, Cerebral Palsy, Convulsion
on Sep 25, 2006 Female patient from UNITED STATES , weighting 8.82 lb, was treated with Oxytocin (View Usage). After Oxytocin was administered, patient had the following side effects: asphyxia, bradycardia foetal, cerebral palsy, convulsion. Oxytocin dosage: .

5346078-2 | Asphyxia, Bradycardia Foetal, Cerebral Palsy, Convulsion
Patient was taking Oxytocin (View Usage). Patient experienced the following unwanted or unexpected effects: asphyxia, bradycardia foetal, cerebral palsy, convulsion on Sep 25, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 8.82 lb, . Oxytocin dosage: .

5345735-1 | Uterine Rupture
Adverse event was reported on Sep 25, 2006 by a Female patient taking Oxytocin (View Usage) (Dosage: ) was diagnosed with labour induction and. Location: UNITED STATES , 30 years of age, Patient had the following side effects: uterine rupture.

5333165-8 | Shock Haemorrhagic, Uterine Haemorrhage
on May 11, 2007 Female patient from JAPAN , 25 years of age, was diagnosed with labour pain and was treated with Oxytocin (View Usage). After Oxytocin was administered, patient had the following side effects: shock haemorrhagic, uterine haemorrhage. Oxytocin dosage: Unk. During the same period patient was treated with PENTAZOCINE LACTATE (Unk) (View Pentazocine Lactate Review and Pentazocine Lactate Label ). Patient was hospitalized.

5306352-2 | Neonatal Tachypnoea
on Apr 12, 2007 Male patient from UNITED STATES , weighting 6.39 lb, was treated with Oxytocin (View Usage). Patient experienced the following unwanted or unexpected effects: neonatal tachypnoea. Oxytocin dosage: . During the same period patient was treated with METHERGINE (View Methergine Review and Methergine Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), PENTAZOCINE LACTATE (View Pentazocine Lactate Review and Pentazocine Lactate Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), PIPAMPERONE (View Pipamperone Review and Pipamperone Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ).

5305315-0 | Neonatal Tachypnoea
Patient was taking Oxytocin (View Usage). Patient had the following side effects: neonatal tachypnoea on Apr 12, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 6.39 lb, . Oxytocin dosage: . During the same period patient was treated with METHERGINE (View Methergine Review and Methergine Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), PENTAZOCINE LACTATE (View Pentazocine Lactate Review and Pentazocine Lactate Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), PIPAMPERONE (View Pipamperone Review and Pipamperone Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ).